HIGHLIGHTS
- who: Wei Zhou et al. from the Hospital, China Jinan University, China have published the paper: Risk factors for post-transplant relapse and survival in younger adult patients with t(8;21)(q22;q22) acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study, in the Journal: (JOURNAL)
- what: This study demonstrated that pretransplant MRD directly before allo-HSCT > 1-log reduction and posttransplant MRD within the first 3 months > 3-log reduction were independent favorable prognostic factors, and transplantation during relapse was an independent adverse prognostic factor for post-transplant relapse . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.